The role of cyclin D1 in response to longterm exposure to ionizing radiation

Cell Cycle

Volumn 12, Issue 17, 2013, Pages 2738-2743

  Shimura, Tsutomu ^a   Fukumoto, Manabu ^b   Kunugita, Naoki ^a  

^a NATIONAL INSTITUTE OF PUBLIC HEALTH   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

Author keywords

AKT; Cyclin D1; Double strand breaks; Long term fractionated radiation; Radioprotection

Indexed keywords

CYCLIN D1; F BOX PROTEIN; F BOX PROTEIN 31; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; UNCLASSIFIED DRUG;

CANCER RISK; CELL PROLIFERATION; CELL SURVIVAL; DNA REPLICATION; G1 PHASE CELL CYCLE CHECKPOINT; GENOMIC INSTABILITY; HUMAN; IONIZING RADIATION; LONG TERM EXPOSURE; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RADIATION DOSE; RADIATION PROTECTION; RADIATION SAFETY; RADIOSENSITIVITY; REVIEW; X RAY;

AKT; CYCLIN D1; DOUBLE-STRAND BREAKS; LONG-TERM FRACTIONATED RADIATION; RADIOPROTECTION;

ANIMALS; CELL CYCLE; CYCLIN D1; FEEDBACK, PHYSIOLOGICAL; HUMANS; RADIATION TOLERANCE; RADIATION, IONIZING; TIME FACTORS;

EID: 84883590255     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.25746     Document Type: Review

References (65)

1. Elkind MM. Repair processes in radiation biology. Radiat Res 1984; 100:425-49; PMID:6390488; http://dx.doi.org/10.2307/3576409
2. Ciccia A, Elledge SJ. The DNA damage response: making it safe to play with knives. Mol Cell 2010; 40:179-204; PMID:20965415; http://dx.doi.org/10. 1016/j.molcel.2010.09.019
3. Agami R, Bernards R. Distinct initiation and maintenance mechanisms cooperate to induce G1 cell cycle arrest in response to DNA damage. Cell 2000; 102:55-66; PMID:10929713; http://dx.doi.org/10.1016/S0092-8674(00)00010-6
4. Cann KL, Hicks GG. Regulation of the cellular DNA double-strand break response. Biochem Cell Biol 2007; 85:663-74; PMID:18059525; http://dx.doi.org/ 10.1139/O07-135
5. Harper JW, Elledge SJ. The DNA damage response: ten years after. Mol Cell 2007; 28:739-45; PMID:18082599; http://dx.doi.org/10.1016/j.molcel.2007.11.015
6. Lakin ND, Jackson SP. Regulation of p53 in response to DNA damage. Oncogene 1999; 18:7644-55; PMID:10618704; http://dx.doi.org/10.1038/sj.onc. 1203015
7. Zhou L, Yuan R, Serggio L. Molecular mechanisms of irradiation-induced apoptosis. Front Biosci 2003; 8:d9-19; PMID:12456331; http://dx.doi.org/10.2741/ 927
8. Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol 2007; 35:495-516; PMID:17562483; http://dx.doi.org/10.1080/01926230701320337
9. Shimura T, Kakuda S, Ochiai Y, Nakagawa H, Kuwahara Y, Takai Y, Kobayashi J, Komatsu K, Fukumoto M. Acquired radioresistance of human tumor cells by DNA-PK/AKT/GSK3beta-mediated cyclin D1 overexpression. Oncogene 2010; 29:4826-37; PMID:20562919; http://dx.doi.org/10.1038/onc.2010.238
10. Shimura T. Acquired radioresistance of cancer and the AKT/GSK3β/cyclin D1 overexpression cycle. J Radiat Res 2011; 52:539-44; PMID:21881296; http://dx.doi.org/10.1269/jrr.11098
11. Diehl JA, Cheng M, Roussel MF, Sherr CJ. Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev 1998; 12:3499-511; PMID:9832503; http://dx.doi.org/10.1101/gad.12.22.3499
12. Vivanco I, Sawyers CL. The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev Cancer 2002; 2:489-501; PMID:12094235; http://dx.doi.org/10.1038/nrc839
13. Manning BD, Cantley LC. AKT/PKB signaling: navigating downstream. Cell 2007; 129:1261-74; PMID:17604717; http://dx.doi.org/10.1016/j.cell.2007.06.009
14. Filmus J, Robles AI, Shi W, Wong MJ, Colombo LL, Conti CJ. Induction of cyclin D1 overexpression by activated ras. Oncogene 1994; 9:3627-33; PMID:7970723
15. Nicholson KM, Anderson NG. The protein kinase B/Akt signalling pathway in human malignancy. Cell Signal 2002; 14:381-95; PMID:11882383; http://dx.doi.org/10.1016/S0898-6568(01)00271-6
16. Alt JR, Cleveland JL, Hannink M, Diehl JA. Phosphorylation-dependent regulation of cyclin D1 nuclear export and cyclin D1-dependent cellular transformation. Genes Dev 2000; 14:3102-14; PMID:11124803; http://dx.doi.org/10. 1101/gad.854900
17. Massagué J. G1 cell-cycle control and cancer. Nature 2004; 432:298-306; PMID:15549091; http://dx.doi.org/10.1038/nature03094
18. Polyak K, Kato JY, Solomon MJ, Sherr CJ, Massague J, Roberts JM, Koff A. p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. Genes Dev 1994; 8:9-22; PMID:8288131; http://dx.doi.org/10.1101/gad.8.1.9
19. Sherr CJ, Roberts JM. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 1999; 13:1501-12; PMID:10385618; http://dx.doi.org/10.1101/gad.13.12.1501
20. Yang K, Guo Y, Stacey WC, Harwalkar J, Fretthold J, Hitomi M, Stacey DW. Glycogen synthase kinase 3 has a limited role in cell cycle regulation of cyclin D1 levels. BMC Cell Biol 2006; 7:33; PMID:16942622; http://dx.doi.org/10.1186/ 1471-2121-7-33
21. Aggarwal P, Lessie MD, Lin DI, Pontano L, Gladden AB, Nuskey B, Goradia A, Wasik MA, Klein-Szanto AJ, Rustgi AK, et al. Nuclear accumulation of cyclin D1 during S phase inhibits Cul4-dependent Cdt1 proteolysis and triggers p53-dependent DNA rereplication. Genes Dev 2007; 21:2908-22; PMID:18006686; http://dx.doi.org/10.1101/gad.1586007
22. Shimura T, Ochiai Y, Noma N, Oikawa T, Sano Y, Fukumoto M. Cyclin D1 overexpression perturbs DNA replication and induces replication-associated DNA double-strand breaks in acquired radioresistant cells. Cell Cycle 2013; 12:773-82; PMID:23388457; http://dx.doi.org/10.4161/cc.23719
23. Santra MK, Wajapeyee N, Green MR. F-box protein FBXO31 mediates cyclin D1 degradation to induce G1 arrest after DNA damage. Nature 2009; 459:722-5; PMID:19412162; http://dx.doi.org/10.1038/nature08011
24. Wang X, Arai S, Song X, Reichart D, Du K, Pascual G, Tempst P, Rosenfeld MG, Glass CK, Kurokawa R. Induced ncRNAs allosterically modify RNA-binding proteins in cis to inhibit transcription. Nature 2008; 454:126-30; PMID:18509338; http://dx.doi.org/10.1038/nature06992
25. Tan J, Geng L, Yazlovitskaya EM, Hallahan DE. Protein kinase B/Akt-dependent phosphorylation of glycogen synthase kinase-3beta in irradiated vascular endothelium. Cancer Res 2006; 66:2320-7; PMID:16489037; http://dx.doi.org/10.1158/0008-5472.CAN-05-2700
26. Hawkins AJ, Golding SE, Khalil A, Valerie K. DNA double-strand break-induced pro-survival signaling. Radiother Oncol 2011; 101:13-7; PMID:21726915; http://dx.doi.org/10.1016/j.radonc.2011.05.074
27. Bozulic L, Surucu B, Hynx D, Hemmings BA. PKBalpha/Akt1 acts downstream of DNA-PK in the DNA double-strand break response and promotes survival. Mol Cell 2008; 30:203-13; PMID:18439899; http://dx.doi.org/10.1016/j.molcel.2008.02. 024
28. Fukami-Kobayashi J, Mitsui Y. Cyclin D1 inhibits cell proliferation through binding to PCNA and cdk2. Exp Cell Res 1999; 246:338-47; PMID:9925749; http://dx.doi.org/10.1006/excr.1998.4306
29. Prosperi E, Scovassi AI, Stivala LA, Bianchi L. Proliferating cell nuclear antigen bound to DNA synthesis sites: phosphorylation and association with cyclin D1 and cyclin A. Exp Cell Res 1994; 215:257-62; PMID:7982468; http://dx.doi.org/10.1006/excr.1994.1341
30. Xiong Y, Zhang H, Beach D. D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA. Cell 1992; 71:505-14; PMID:1358458; http://dx.doi.org/10.1016/0092-8674(92)90518-H
31. Shimura T, Torres MJ, Martin MM, Rao VA, Pommier Y, Katsura M, Miyagawa K, Aladjem MI. Bloom's syndrome helicase and Mus81 are required to induce transient double-strand DNA breaks in response to DNA replication stress. J Mol Biol 2008; 375:1152-64; PMID:18054789; http://dx.doi.org/10.1016/j.jmb.2007.11. 006
32. Tane S, Chibazakura T. Cyclin A overexpression induces chromosomal double-strand breaks in mammalian cells. Cell Cycle 2009; 8:3900-3; PMID:19901524; http://dx.doi.org/10.4161/cc.8.23.10071
33. Pernot E, Hall J, Baatout S, Benotmane MA, Blanchardon E, Bouffler S, El Saghire H, Gomolka M, Guertler A, Harms-Ringdahl M, et al. Ionizing radiation biomarkers for potential use in epidemiological studies. Mutat Res 2012; 751:258-86; PMID:22677531; http://dx.doi.org/10.1016/j.mrrev.2012.05.003
34. Lassmann M, Hänscheid H, Gassen D, Biko J, Meineke V, Reiners C, Scherthan H. In vivo formation of gamma-H2AX and 53BP1 DNA repair foci in blood cells after radioiodine therapy of differentiated thyroid cancer. J Nucl Med 2010; 51:1318-25; PMID:20660387; http://dx.doi.org/10.2967/jnumed.109.071357
35. Gillett C, Fantl V, Smith R, Fisher C, Bartek J, Dickson C, Barnes D, Peters G. Amplification and overexpression of cyclin D1 in breast cancer detected by immunohistochemical staining. Cancer Res 1994; 54:1812-7; PMID:8137296
36. Russell A, Thompson MA, Hendley J, Trute L, Armes J, Germain D. Cyclin D1 and D3 associate with the SCF complex and are coordinately elevated in breast cancer. Oncogene 1999; 18:1983-91; PMID:10208420; http://dx.doi.org/10.1038/sj. onc.1202511
37. Diehl JA. Cycling to cancer with cyclin D1. Cancer Biol Ther 2002; 1:226-31; PMID:12432268
38. Fu M, Rao M, Bouras T, Wang C, Wu K, Zhang X, Li Z, Yao TP, Pestell RG. Cyclin D1 inhibits peroxisome proliferator-activated receptor gamma-mediated adipogenesis through histone deacetylase recruitment. J Biol Chem 2005; 280:16934-41; PMID:15713663; http://dx.doi.org/10.1074/jbc.M500403200
39. Hulit J, Wang C, Li Z, Albanese C, Rao M, Di Vizio D, Shah S, Byers SW, Mahmood R, Augenlicht LH, et al. Cyclin D1 genetic heterozygosity regulates colonic epithelial cell differentiation and tumor number in ApcMin mice. Mol Cell Biol 2004; 24:7598-611; PMID:15314168; http://dx.doi.org/10.1128/MCB.24.17. 7598-7611.2004
40. Casimiro MC, Pestell RG. Cyclin d1 induces chromosomal instability. Oncotarget 2012; 3:224-5; PMID:22538871
41. Lung JC, Chu JS, Yu JC, Yue CT, Lo YL, Shen CY, Wu CW. Aberrant expression of cell-cycle regulator cyclin D1 in breast cancer is related to chromosomal genomic instability. Genes Chromosomes Cancer 2002; 34:276-84; PMID:12007188; http://dx.doi.org/10.1002/gcc.10072
42. Quelle DE, Ashmun RA, Shurtleff SA, Kato JY, Bar-Sagi D, Roussel MF, Sherr CJ. Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts. Genes Dev 1993; 7:1559-71; PMID:8339933; http://dx.doi.org/10.1101/ gad.7.8.1559
43. Benzeno S, Lu F, Guo M, Barbash O, Zhang F, Herman JG, Klein PS, Rustgi A, Diehl JA. Identification of mutations that disrupt phosphorylation-dependent nuclear export of cyclin D1. Oncogene 2006; 25:6291-303; PMID:16732330; http://dx.doi.org/10.1038/sj.onc.1209644
44. Gladden AB, Diehl JA. Location, location, location: the role of cyclin D1 nuclear localization in cancer. J Cell Biochem 2005; 96:906-13; PMID:16163738; http://dx.doi.org/10.1002/jcb.20613
45. Lin DI, Lessie MD, Gladden AB, Bassing CH, Wagner KU, Diehl JA. Disruption of cyclin D1 nuclear export and proteolysis accelerates mammary carcinogenesis. Oncogene 2008; 27:1231-42; PMID:17724472; http://dx.doi.org/10. 1038/sj.onc.1210738
46. Mallette FA, Gaumont-Leclerc MF, Ferbeyre G. The DNA damage signaling pathway is a critical mediator of oncogene-induced senescence. Genes Dev 2007; 21:43-8; PMID:17210786; http://dx.doi.org/10.1101/gad.1487307
47. Bartkova J, Rezaei N, Liontos M, Karakaidos P, Kletsas D, Issaeva N, Vassiliou LV, Kolettas E, Niforou K, Zoumpourlis VC, et al. Oncogeneinduced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature 2006; 444:633-7; PMID:17136093; http://dx.doi.org/10.1038/ nature05268
48. Di Micco R, Fumagalli M, Cicalese A, Piccinin S, Gasparini P, Luise C, Schurra C, Garre' M, Nuciforo PG, Bensimon A, et al. Oncogene-induced senescence is a DNA damage response triggered by DNA hyper-replication. Nature 2006; 444:638-42; PMID:17136094; http://dx.doi.org/10.1038/nature05327
49. Murfuni I, Nicolai S, Baldari S, Crescenzi M, Bignami M, Franchitto A, et al. The WRN and MUS81 proteins limit cell death and genome instability following oncogene activation. Oncogene 2013; 32:610-20; PMID:22410776; http://dx.doi.org/10.1038/onc.2012.80
50. Dulić V, Drullinger LF, Lees E, Reed SI, Stein GH. Altered regulation of G1 cyclins in senescent human diploid fibroblasts: accumulation of inactive cyclin E-Cdk2 and cyclin D1-Cdk2 complexes. Proc Natl Acad Sci U S A 1993; 90:11034-8; PMID:8248208; http://dx.doi.org/10.1073/pnas.90.23.11034
51. Lucibello FC, Sewing A, Brüsselbach S, Bürger C, Müller R. Deregulation of cyclins D1 and E and suppression of cdk2 and cdk4 in senescent human fibroblasts. J Cell Sci 1993; 105:123-33; PMID:8360268
52. Atadja P, Wong H, Veillete C, Riabowol K. Overexpression of cyclin D1 blocks proliferation of normal diploid fibroblasts. Exp Cell Res 1995; 217:205-16; PMID:7698220; http://dx.doi.org/10.1006/excr.1995.1080
53. Leontieva OV, Lenzo F, Demidenko ZN, Blagosklonny MV. Hyper-mitogenic drive coexists with mitotic incompetence in senescent cells. Cell Cycle 2012; 11:4642-9; PMID:23187803; http://dx.doi.org/10.4161/cc.22937
54. Duronio V. The life of a cell: apoptosis regulation by the PI3K/PKB pathway. Biochem J 2008; 415:333-44; PMID:18842113; http://dx.doi.org/10.1042/ BJ20081056
55. Song G, Ouyang G, Bao S. The activation of Akt/PKB signaling pathway and cell survival. J Cell Mol Med 2005; 9:59-71; PMID:15784165; http://dx.doi.org/ 10.1111/j.1582-4934.2005.tb00337.x
56. Dent P, Yacoub A, Contessa J, Caron R, Amorino G, Valerie K, Hagan MP, Grant S, Schmidt-Ullrich R. Stress and radiation-induced activation of multiple intracellular signaling pathways. Radiat Res 2003; 159:283-300; PMID:12600231; http://dx.doi.org/10.1667/0033-7587(2003)159[0283:SARIAO]2 .0.CO;2
57. Schmidt-Ullrich RK, Contessa JN, Dent P, Mikkelsen RB, Valerie K, Reardon DB, Bowers G, Lin PS. Molecular mechanisms of radiation-induced accelerated repopulation. Radiat Oncol Investig 1999; 7:321-30; PMID:10644055; http://dx.doi.org/10.1002/(SICI)1520-6823(1999)7:6 3.0.CO;2-Q
58. Alao JP. The regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic invention. Mol Cancer 2007; 6:24; PMID:17407548; http://dx.doi.org/10.1186/1476-4598-6-24
59. Musgrove EA, Caldon CE, Barraclough J, Stone A, Sutherland RL. Cyclin D as a therapeutic target in cancer. Nat Rev Cancer 2011; 11:558-72; PMID:21734724; http://dx.doi.org/10.1038/nrc3090
60. Jayasurya R, Francis G, Kannan S, Lekshminarayanan K, Nalinakumari KR, Abraham T, Abraham EK, Nair MK. p53, p16 and cyclin D1: molecular determinants of radiotherapy treatment response in oral carcinoma. Int J Cancer 2004; 109:710-6; PMID:14999779; http://dx.doi.org/10.1002/ijc.20042
61. Higuchi E, Oridate N, Homma A, Suzuki F, Atago Y, Nagahashi T, Furuta Y, Fukuda S. Prognostic significance of cyclin D1 and p16 in patients with intermediate-risk head and neck squamous cell carcinoma treated with docetaxel and concurrent radiotherapy. Head Neck 2007; 29:940-7; PMID:17563903; http://dx.doi.org/10.1002/hed.20632
62. Yang L, Dan HC, Sun M, Liu Q, Sun XM, Feldman RI, Hamilton AD, Polokoff M, Nicosia SV, Herlyn M, et al. Akt/protein kinase B signaling inhibitor-2, a selective small molecule inhibitor of Akt signaling with antitumor activity in cancer cells overexpressing Akt. Cancer Res 2004; 64:4394-9; PMID:15231645; http://dx.doi.org/10.1158/0008-5472.CAN-04-0343
63. Feun LG, Blessing JA, Barrett RJ, Hanjani P. A phase II trial of tricyclic nucleoside phosphate in patients with advanced squamous cell carcinoma of the cervix. A Gynecologic Oncology Group Study. Am J Clin Oncol 1993; 16:506-8; PMID:8256767; http://dx.doi.org/10.1097/00000421-199312000-00010
64. Feun LG, Savaraj N, Bodey GP, Lu K, Yap BS, Ajani JA, Burgess MA, Benjamin RS, McKelvey E, Krakoff I. Phase I study of tricyclic nucleoside phosphate using a five-day continuous infusion schedule. Cancer Res 1984; 44:3608-12; PMID:6744283
65. Shimura T, Kakuda S, Ochiai Y, Kuwahara Y, Takai Y, Fukumoto M. Targeting the AKT/GSK3β/cyclin D1/Cdk4 survival signaling pathway for eradication of tumor radioresistance acquired by fractionated radiotherapy. Int J Radiat Oncol Biol Phys 2011; 80:540-8; PMID:21398050; http://dx.doi.org/10.1016/j.ijrobp. 2010.12.065